Baricitinib in rheumatoid arthritis-interstitial lung disease: national multicenter study of 72 patients and literature review.
Serrano-Combarro A, Atienza-Mateo B, Martín-Gutiérrez A, Loarce Martos J, Dubuc CAE, Pastor Mena M, Melero-Gonzalez RB, Martín López M, Mena Vázquez N, Carrasco-Cubero C, Pérez García C, Valle AG, Bonilla G, Blanco Madrigal JM, Astigarraga-Urquia U, Vegas Revenga N, Albadalejo LP, Ortega Castro R, Sánchez DP, Fernández Ortiz AM, Viejo PL, Lasanta ML, Garijo Bufort M, Casafont Solé I, Lamua-Riazuelo JR, Abascal IB, Ruiz-Esquide V, Perez EC, Flores Robles BJ, Martínez-Vidal MP, Moreno Morales J, Urruticoechea-Arana A, Rosas J, Fernández Lozano D, Castro Corredor D, Ferraz-Amaro I, Castañeda S, Blanco R; Spanish Collaborative Group of JAKi in Interstitial Lung Disease Associated with Rheumatoid Arthritis.
Serrano-Combarro A, et al. Among authors: lasanta ml.
Rheumatology (Oxford). 2025 Jun 10:keaf314. doi: 10.1093/rheumatology/keaf314. Online ahead of print.
Rheumatology (Oxford). 2025.
PMID: 40493905